October 28, 2016

Diabetes Solutions

The prevalence of diabetes is expected to increase 65% in the next 25 years – and having one global partner to support your diabetes research from discovery to post-market can make all the difference.

Download the infographic to learn how Q2 Solutions supports our customers across the development continuum in their fight against the global diabetes epidemic by using deeper science to drive tailored solutions, optimized quality systems, delivery excellence and better insights.

We offer a complete range of diabetes drug development solutions including central, bioanalytical, ADME and genomics labs – plus support for companion diagnostic studies for personalized medicine.

Related Services:
Q2 Solutions Biomarker Services

Providing tools and experience to maximize your biomarker strategy

Bioanalytical & ADME Laboratory Services

Accelerate and enhance your discovery, preclinical and clinical programs

In Vitro ADME & Metabolite Identification Services List

Services to support your In Vitro ADME development needs

Read More